Cord blood disorders is speculative, some research has been done in other areas. Any such potential beyond blood and immunological uses is limited by the fact that cord cells are hematopoietic stem cells (which can differentiate only into blood cells), and not pluripotent stem cells (such as embryonic stem cells, which can differentiate into any type of tissue). Cord blood has been studied as a treatment for diabetes. However, apart from blood disorders, the use of cord blood for other diseases is not in routine clinical use and remains a major challenge for the stem cell community. Along with cord blood, Wharton's
Blood Centers of the Pacific and BCP are considered one of the country's foremost research laboratories in transfusion medicine. Blood Centers of the Pacific Blood Centers of the Pacific is a community based, nonprofit blood center that collects blood donations and provides safe blood and blood components for transfusion and also related services to more than 40 hospitals in the Bay Area and Northern California. An affiliate of United Blood Services, the second largest blood collection organization in the U.S., it also houses the Blood Systems Research Institute Blood Centers of the Pacific (BCP) is a nonprofit 501(c)(3) organization. BCP is licensed by the U.S.